ID   MD155
AC   CVCL_B4UK
DR   Wikidata; Q110433023
RX   PubMed=28832583;
CC   From: Ludwig Institute for Cancer Research, Lausanne Branch; Lausanne; Switzerland.
CC   HLA typing: A*02:01,24:02; B*15:01,18:01; C*03:03,07:01 (PubMed=28832583).
CC   HLA typing: DQB1*03,06; DRB1*11,13 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Miscellaneous: HLA class II typing from personal communication of Bassani-Sternberg, Michal.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
RX   PubMed=28832583; DOI=10.1371/journal.pcbi.1005725; PMCID=PMC5584980;
RA   Bassani-Sternberg M., Chong C., Guillaume P., Solleder M., Pak H.,
RA   Gannon P.O., Kandalaft L.E., Coukos G., Gfeller D.;
RT   "Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen
RT   predictions and identifies allostery regulating HLA specificity.";
RL   PLoS Comput. Biol. 13:e1005725.1-e1005725.28(2017).
//